J. Jay Cho Ph.D.

J. Jay Cho Ph.D.

Patterson Belknap Webb & Tyler LLP

Contact
View Bio
RSS

Latest Posts › Patent Infringement

Share:

Federal Circuit Walks Back Its “Exceptional” Stance on the Doctrine of Equivalents in the Latest Amgen v. Sandoz Decision

In Amgen’s long-running dispute with biosimilar-maker Sandoz over biosimilar versions of Amgen’s filgrastim (Neupogen®) and pegfilgrastim (Neulasta®) biologics, the Federal Circuit earlier this year affirmed summary judgment...more

9/6/2019  /  Biosimilars , Doctrine of Equivalents , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Patents , Popular , Sandoz v Amgen
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide